HomeUSASanté Ventures Exits Laminar

Santé Ventures Exits Laminar

Santé Ventures, an Austin, TX- and Boston, MA-based early-stage healthcare and life sciences investment firm, has announced the acquisition of its Fund III portfolio company, Laminar, Inc., by Johnson & Johnson Medtech.

The purchase was completed with an upfront payment of $400M

As Laminar’s venture capital investor, Santé played a role in helping develop the company’s novel approach to eliminating the left atrial appendage (LAA) in patients with non-valvular AFib. Laminar will join Johnson & Johnson MedTech as part of Biosense Webster, Inc. – a global leader in cardiac arrhythmia treatment.

Founded in 2006, Santé Ventures is a specialized healthcare and life sciences investment firm with roughly $800M in capital under management. The firm invests in early-stage companies developing innovative new medical technologies, biotechnologies, and digitally enabled healthcare services.

Recent Santé successes include Laminar (Johnson & Johnson), Farapulse (Boston Scientific), Claret Medical (Boston Scientific), TVA Medical (Becton Dickinson), Millipede Medical (Boston Scientific), Molecular Templates (MTEM), AbVitro (Bristol Myers Squibb), and Explorys (IBM Corp).